Concepedia

Publication | Open Access

Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial

DOIFull Paper Access

24

Citations

20

References

2023

Year

Yixing Chen, Ping Yang, Shisuo Du, Yuan Zhuang, Cheng Huang, Yong Hu, Wenchao Zhu, Yiyi Yu, Tianshu Liu, Zhao‐Chong Zeng
World Journal of Gastroenterology

Abstract

SBRT plus sintilimab is an effective, well-tolerated treatment regimen for patients with recurrent or oligometastatic HCC.

References

YearCitations

Page 1